Carbetocin versus oxytocin for the prevention of uterine atony during cesarean delivery: a real-world retrospective historical control cohort study (2022–2023) | Synapse
March 3, 2026
Carbetocin versus oxytocin for the prevention of uterine atony during cesarean delivery: a real-world retrospective historical control cohort study (2022–2023)
Puntos clave
Carbetocin is shown to be more effective than oxytocin in preventing uterine atony during cesarean delivery.
In the cohort analysis, carbetocin had a significantly lower incidence of uterine atony compared to oxytocin.
The retrospective analysis involved reviewing medical records between 2022 and 2023 for evidence.
These findings support the consideration of carbetocin as a preferred choice for preventing uterine atony.